Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Ho

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
RNA (New York, N.Y.)|October 19, 2007
A bipartite U1 site represses U1A expression by synergizing with PIE to inhibit nuclear polyadenylationFei Guan, Rose M Caratozzolo, Rafal Goraczniak, et al.
Neural Regeneration Research|March 9, 2022
Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injuryMing-Xi Li, Jing-Wen Weng, Eric S Ho, et al.
Frontiers in Neuroscience|March 3, 2020
Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic StrokeDan Lu, Eric S Ho, Hongcheng Mai, et al.
Molecular Cancer Therapeutics|April 6, 2017
U1 Adaptors Suppress the <i>KRAS-MYC</i> Oncogenic Axis in Human Pancreatic Cancer XenograftsAshley T Tsang, Crissy Dudgeon, Lan Yi, et al.
Molecular Therapy. Nucleic Acids|May 16, 2013
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In VivoRafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Molecular Therapy. Nucleic Acids|January 16, 2025
Erratum: U1 Adaptor Oligonucleotides Targeting <i>BCL2</i> and <i>GRM1</i> Suppress Growth of Human Melanoma Xenografts <i>In Vivo</i>Rafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
RNA (New York, N.Y.)|October 19, 2007
A bipartite U1 site represses U1A expression by synergizing with PIE to inhibit nuclear polyadenylationFei Guan, Rose M Caratozzolo, Rafal Goraczniak, et al.
Neural Regeneration Research|March 9, 2022
Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injuryMing-Xi Li, Jing-Wen Weng, Eric S Ho, et al.
Frontiers in Neuroscience|March 3, 2020
Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic StrokeDan Lu, Eric S Ho, Hongcheng Mai, et al.
Molecular Cancer Therapeutics|April 6, 2017
U1 Adaptors Suppress the <i>KRAS-MYC</i> Oncogenic Axis in Human Pancreatic Cancer XenograftsAshley T Tsang, Crissy Dudgeon, Lan Yi, et al.
Molecular Therapy. Nucleic Acids|May 16, 2013
U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In VivoRafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Molecular Therapy. Nucleic Acids|January 16, 2025
Erratum: U1 Adaptor Oligonucleotides Targeting <i>BCL2</i> and <i>GRM1</i> Suppress Growth of Human Melanoma Xenografts <i>In Vivo</i>Rafal Goraczniak, Brian A Wall, Mark A Behlke, et al.
Pageof 2